Jeff Alder

Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact

Jared Silverman, Lawrence I. Mortin, Andrew D. G. VanPraagh et al. · The Journal of Infectious Diseases · 2005 · 531 citations · Full text

Pharmaceutical Science, Pulmonary Surfactant, Antimicrobial Chemotherapy +16

Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in <i>Staphylococcus aureus</i>

Lisa Friedman, Jeff Alder, Jared Silverman · Antimicrobial Agents and Chemotherapy · 2006 · 452 citations · Full text

Genetics, Molecular Biology, Antibiotic Resistance +20

Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing <i>Staphylococcus aureus</i> Cells

Carmela Mascio, Jeff Alder, Jared Silverman · Antimicrobial Agents and Chemotherapy · 2007 · 277 citations · Full text

Antimicrobial Chemotherapy, Drug Resistance, Infection Control +17

Induction of Daptomycin Heterogeneous Susceptibility in <i>Staphylococcus aureus</i> by Exposure to Vancomycin

George Sakoulas, Jeff Alder, C Thauvin-Eliopoulos et al. · Antimicrobial Agents and Chemotherapy · 2006 · 261 citations · Full text

Antimicrobial Chemotherapy, Antibiotic Resistance, Bacterial Pathogens +17

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

Robert Wilson, Tobias Welte, Eva Polverino et al. · European Respiratory Journal · 2012 · 200 citations · Full text

Pulmonary Care, Inflammatory Lung Disease, Advanced Lung Disease +17